Predictive value of transcutaneous bilirubinometry on third day of birth in diagnosis of hyperbilirubinemia in term and near-term neonates

References

• 1.
  Martin RJ, Fanaroff AA, Walsh MC. Fanaroff and Martin's neonatal-perinatal medicine: diseases of the fetus and infant: Elsevier Health Sciences; 2010.
• 2.
  Newman TB, Liljestrand P, Escobar GJ. Combining clinical risk factors with serum bilirubin levels to predict hyperbilirubinemia in newborns.Arch Pediatr Adolesc Med 2005; 159:113.
• 3.
  Bolbol-Haghighi N, Masoumi SZ, Kazemi F.Effect of continued support of midwifery students in labour on the childbirth and labour consequences: arandomized controlled clinical trial. J Clin Diagn Res 2016; 10:QC14.
• 4.
  Bhutani VK, Johnson L. Prevention of severe neonatal hyperbilirubinemia in healthy infants of 35 or more weeks of gestation: implementation of a systems-based approach. J Pediatr 2007; 83:289-293.
• 5.
  Rostami N, Shahverdizadeh M. Determining the diagnostic power of transcutaneous bilirubinometry (TCB). J Research in Medicine. 2007;31:351-3.
• 6.
  American Academy of Pediatrics Subcommittee on Hyperbilirubinemia.Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004; 114:297.
• 7.
  Bhutani VK, Johnson LH, Keren R. Diagnosis and management of hyperbilirubinemia in the term neonate: for a safer first week. Pediatr Clin 2004; 51:843-861.
• 8.
  Martnez JC. International perspectives: neonatal jaundice: building a culture of safety (an argentinean perspective). Neo Rev 2012; 13:e77-e80.
• 9.
  Soorani-Lunsing I, Woltil HA, Hadders-Algra M. Are moderate degrees of hyperbilirubinemia in healthy term neonates really safe for the brain? Pediatr Res 2001; 50:701-705.
• 10.
  Mokhtari Amir Majdi N, Boskabadi H, Khalesi H. Evaluation of auditory brainstem response (ABR) in neonatal hyperbilirubinemia. Iran J Otorhinolaryngology 2008; 20:27-32.(Persian).
• 11.
  Nabavi S, Behzad Moghadam M, Arab Hosseini M, Vaezi M, Rajabi R. Evaluation of auditory brainstem responses (ABR) in healthy term infants with elevated bilirubin levels requiring exchange transfusion. ZUMS J 2011; 19:77-83. (Persian).
• 12.
  Maisels MJ, Bhutani VK, Bogen D, Newman TB, Stark AR, Watchko JF. Hyperbilirubinemia in the newborn infant 35 weeks gestation: an update with clarifications. Pediatrics 2009; 124:1193-1198.
• 13.
  Imani M, Mohammadi M. Comparison of change pattern of serum and transcutaneous bilirubin in hyper bilirubinemic neonates. 2004. (Persian).
• 14.
  Carceller-Blanchard A, Cousineau J, Delvin E. Point of care testing: transcutaneous bilirubinometry in neonates. Clin Biochem 2009; 42:143-149.
• 15.
  Kasiri KA, Nourbakhsh SM, Boroujeni TK, Khoshdel A. Correlation of transcutaneous and serum bilirubin levels in infants with neonatal jaundice hospitalized in Hajar Hospital in Shahrekord. Pajoohandeh J 2013; 18:189-194. (Persian).
• 16.
  Boo NY, Ishak S. Prediction of severe hyperbilirubinaemia using the Bilicheck transcutaneous bilirubinometer. J Paediatr Child Health 2007;43:297-302.
• 17.
  Samanta S, Tan M, Kissack C, Nayak S, Chittick R, Yoxall C. The value of Bilicheck as a screening tool for neonatal jaundice in term and nearterm babies. Acta Paediat 2004; 93:1486-1490.
• 18.
  Kolman KB, Mathieson KM, Frias C. A comparison of transcutaneous and total serum bilirubin in newborn Hispanic infants at 35 or more weeks of gestation.J Am Board Fam Med 2007; 20:266-271.
• 19.
  Mansouri M, Mahmoodnejad A, Taghizadeh Sarvestani R, Gharibi F. A comparison between transcutaneous bilirubin (TcB) and total serum bilirubin (TSB) measurements in term neonates. Int J Pediatr 2015; 3:633-641.
• 20.
  Mahram M, Oveisi S, Jaberi N. Trans-Cutaneous Bilirubinometery versus serum bilirubin in neonatal jaundice. Acta Med Iran 2015; 53: 764-769.
• 21.
  Sanpavat S, Nuchprayoon I, Smathakanee C, Hansuebsai R. Nomogram for prediction of the risk of neonatal hyperbilirubinemia, using transcutaneous bilirubin. J Med Assoc Thai 2005; 88:1187-1193.
• 22.
  Afjeh A, Fallahi M, Jahanbeen M, Basiri A, Allaee M. Pre-discharge screening trans-cutaneous bilirubinometry in healthy newborns in Mahdieh hospital, Tehran. IranJ Pediatr 2015; 25: e2187.
• 23.
  Gupta B, Chaudhary N, Bhatia B, Gupta B. Non invasive trans-cutaneous bilirubin as a screening test to identify the need for serum bilirubin assessment in healthy term neonates. J Univ College Med Sci 2014; 1:17-21.
• 24.
  El-Beshbishi SN, Shattuck KE, Mohammad AA, Petersen JR. Hyperbilirubinemia and transcutaneous bilirubinometry. Clin Chem 2009; 55:1280-1287.
• 25.
  De Luca D, Zecca E, De Turris P, Barbato G, Marras M, Romagnoli C. Using BiliCheck for preterm neonates in a sub-intensive unit: Diagnostic usefulness and suitability. Early Hum Dev 2007; 83:313-317.
• 26.
  Mohamed I, Blanchard A, Delvin E, Cousineau J, Carceller A. Plotting transcutaneous bilirubin measurements on specific transcutaneous nomogram results in better prediction of significant hyperbilirubinemia in healthy term and near-term newborns: a pilot study. Neonatology 2014; 105:306-311.
• 27.
  Rasoolyneghad A, Amin Beidokhti M, Rashidy-Pour A, Ghorbany R. Estimation of hyperbilirubinemia by observation of neonate skin withjaundice in Amiralmomenin's hospital of Semnan, 1999. Koomesh 2000; 1:29-33. (Persian)##.